BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11744164)

  • 1. Functional regulatory regions of human transcription factor MEF2C.
    Janson CG; Chen Y; Li Y; Leifer D
    Brain Res Mol Brain Res; 2001 Dec; 97(1):70-82. PubMed ID: 11744164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
    Zhu B; Gulick T
    Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity.
    Kang J; Gocke CB; Yu H
    BMC Biochem; 2006 Feb; 7():5. PubMed ID: 16478538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity.
    Molkentin JD; Li L; Olson EN
    J Biol Chem; 1996 Jul; 271(29):17199-204. PubMed ID: 8663403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C.
    Molkentin JD; Black BL; Martin JF; Olson EN
    Mol Cell Biol; 1996 Jun; 16(6):2627-36. PubMed ID: 8649370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocyte-specific enhancer binding factor 2C expression in human brain development.
    Leifer D; Golden J; Kowall NW
    Neuroscience; 1994 Dec; 63(4):1067-79. PubMed ID: 7700509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
    Zang MX; Li Y; Xue LX; Jia HT; Jing H
    J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
    Maiti D; Xu Z; Duh EJ
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA-dependent recruitment of MEF2 proteins to target promoters.
    Morin S; Charron F; Robitaille L; Nemer M
    EMBO J; 2000 May; 19(9):2046-55. PubMed ID: 10790371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the human GLUT4 gene promoter: interaction between a transcriptional activator and myocyte enhancer factor 2A.
    Knight JB; Eyster CA; Griesel BA; Olson AL
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14725-30. PubMed ID: 14630949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDNA cloning and characterization of 5' upstream promoter region of porcine mef2c gene.
    Liu M; Xu DQ; Peng J; Zheng R; Li F; Jiang SW
    Mol Biol Rep; 2011 Oct; 38(7):4723-30. PubMed ID: 21136170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57.
    Kobarg CB; Kobarg J; Crosara-Alberto DP; Theizen TH; Franchini KG
    FEBS Lett; 2005 May; 579(12):2615-22. PubMed ID: 15862299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hMusTRD1alpha1 represses MEF2 activation of the troponin I slow enhancer.
    Polly P; Haddadi LM; Issa LL; Subramaniam N; Palmer SJ; Tay ES; Hardeman EC
    J Biol Chem; 2003 Sep; 278(38):36603-10. PubMed ID: 12857748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2C.
    Xu J; Cao S; Wang L; Xu R; Chen G; Xu Q
    PLoS One; 2011; 6(11):e27165. PubMed ID: 22073279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
    Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
    Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors.
    Martin JF; Schwarz JJ; Olson EN
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5282-6. PubMed ID: 8506376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
    Grégoire S; Yang XJ
    Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
    Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
    J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation.
    Novitch BG; Spicer DB; Kim PS; Cheung WL; Lassar AB
    Curr Biol; 1999 May; 9(9):449-59. PubMed ID: 10322110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.